Managing the risks of ADHD treatments
Benjamin N Schneider1, Michael Enenbach
1Division of Child & Adolescent Psychiatry, UCLA Semel Institute for Neuroscience & Human Behavior, 760 Westwood Plaza, Suite 68-251A, Los Angeles, CA, 90024, USA, bschneider@mednet.ucla.edu.
Current Psychiatry Reports
|August 20, 2014
Summary
Attention deficit-hyperactivity disorder (ADHD) pharmacotherapy is effective but has side effects. This review details adverse event prevalence and management strategies for ADHD medications.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Medicine
Background:
- Pharmacotherapy is a primary treatment for attention deficit-hyperactivity disorder (ADHD).
- ADHD medications, including stimulants, can cause adverse events.
- Effective risk management is crucial for successful ADHD treatment.
Purpose of the Study:
- To review the prevalence of adverse events associated with ADHD medications.
- To discuss effective strategies for managing risks and side effects.
- To highlight recent updates in ADHD pharmacotherapy management.
Main Methods:
- Literature search of MEDLINE/PubMed and Cochrane databases.
- Keywords focused on adverse events and ADHD medication management.
- Synthesis of data on side effect prevalence and clinical management approaches.
Main Results:
- Adverse events are a significant consideration in ADHD pharmacotherapy.
- Various management strategies exist to mitigate side effects.
- Recent literature provides updated insights into risk management.
Conclusions:
- Understanding and managing adverse events is key to optimizing ADHD pharmacotherapy.
- Clinicians should be aware of the prevalence and management of side effects.
- This review offers guidance on current approaches to ADHD medication management.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.4K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
9.7K
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
01:28Drug Therapy
443
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
443
01:24Drug Toxicity: Risk factors
228
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
228
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:26Modeling in Therapy
811
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
811
01:26Psychosis: Goals of Pharmacotherapy
695
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
695